Hempstract, Inc. (HPST)
Hempstract, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Warden, WA, US. The stock last traded at $0.03, up 2.04% on the session, giving a market capitalisation of $25.5M. On trailing twelve-month figures it carries a trailing P/E of -33.33, a net margin of 0.0%. Its beta of 1.79 implies it has historically moved more than the broad market.
Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG). Its catalog features CBD in isolate powder form, alongside various distillate oils. The enterprise adopted the Hempstract, Inc. moniker in November 2020, having previously been known as Riverdale Oil and Gas Corporation. This firm maintains its principal office in Warden, Washington.
Hempstract, Inc. is most often compared with the following Healthcare names: